ns 1619 and rosiglitazone

ns 1619 has been researched along with rosiglitazone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheon, HG; Kim, KY	1

Other Studies

1 other study(ies) available for ns 1619 and rosiglitazone

Article	Year
Antiangiogenic effect of rosiglitazone is mediated via peroxisome proliferator-activated receptor gamma-activated maxi-K channel opening in human umbilical vein endothelial cells. The Journal of biological chemistry, 2006, May-12, Volume: 281, Issue:19 Topics: Benzimidazoles; Cell Proliferation; Endothelial Cells; Gene Silencing; Humans; Large-Conductance Calcium-Activated Potassium Channels; Neovascularization, Physiologic; PPAR gamma; Rosiglitazone; Thiazolidinediones; Umbilical Veins; Vasodilator Agents	2006

Article

Year

Antiangiogenic effect of rosiglitazone is mediated via peroxisome proliferator-activated receptor gamma-activated maxi-K channel opening in human umbilical vein endothelial cells.

The Journal of biological chemistry, 2006, May-12, Volume: 281, Issue:19

Topics: Benzimidazoles; Cell Proliferation; Endothelial Cells; Gene Silencing; Humans; Large-Conductance Calcium-Activated Potassium Channels; Neovascularization, Physiologic; PPAR gamma; Rosiglitazone; Thiazolidinediones; Umbilical Veins; Vasodilator Agents

2006